The intellectual structure and emerging trends on nanotechnology in inflammatory bowel disease: A bibliometric analysis from 2005 to 2024

BACKGROUND: As a chronic inflammatory disease of the intestine, inflammatory bowel disease (IBD) is challenged by existing treatment methods, such as poor drug targeting, low bioavailability, and systemic toxicity. In recent years, nanotechnology has provided a new strategy for the treatment and diagnosis of IBD due to its advantages of precise delivery, controllable release and multifunctional integration. METHODS: We searched the Web of Science Core Collection database for relevant literature about nanotechnology and IBD published from 2005 to 2024. We used SciExplorer, VOSviewer, and Citespace to analyze countries, institutions, authors, keywords, highly cited references, and co-cited references to discuss research hotspots and trends in this field. RESULTS: The research analysis included a total of 959 pieces of literature, with China and the USA leading in the number of papers published and academic influence. The Georgia State University had the most papers posted. Merlin Didier and Xiao Bo were the scholars who published the most. The research hotspots mainly focus on nanodrug delivery systems, targeted therapy and inflammation regulation, while exosomes, macrophage polarization, and intestinal microbiota regulation are becoming new research frontiers. In the future, intelligent responsive nanomaterials, multifunctional nanoplatforms, and personalized nanotechnology will become important development directions. CONCLUSION: A new avenue for the accurate diagnosis and treatment of IBD has been unlocked by nanotechnology, but its clinical translation needs to break through the bottlenecks of biocompatibility, large-scale preparation and interdisciplinary collaboration. In the future, we should focus on the development of "intelligent responsive nanosystems," deepen the research on the interaction mechanism of "nano-microbe-host," and promote the establishment of a personalized treatment system.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-07-24
DOI
https://doi.org/10.1097/md.0000000000049947
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The intellectual structure and emerging trends on nanotechnology in inflammatory bowel disease: A bibliometric analysis from 2005 to 2024

Dexin Wang, X L Zhang, 岳超驰, L C Li et al.
Medicine
Inflammatory Bowel Disease
article

The intellectual structure and emerging trends on nanotechnology in inflammatory bowel disease: A bibliometric analysis from 2005 to 2024

Dexin Wang, X L Zhang, 岳超驰, L C Li, Gang Tian, Xi Zhang, Lei Liang, Weiliang Du, H Yang
article en

Abstract

BACKGROUND: As a chronic inflammatory disease of the intestine, inflammatory bowel disease (IBD) is challenged by existing treatment methods, such as poor drug targeting, low bioavailability, and systemic toxicity. In recent years, nanotechnology has provided a new strategy for the treatment and diagnosis of IBD due to its advantages of precise delivery, controllable release and multifunctional integration. METHODS: We searched the Web of Science Core Collection database for relevant literature about nanotechnology and IBD published from 2005 to 2024. We used SciExplorer, VOSviewer, and Citespace to analyze countries, institutions, authors, keywords, highly cited references, and co-cited references to discuss research hotspots and trends in this field. RESULTS: The research analysis included a total of 959 pieces of literature, with China and the USA leading in the number of papers published and academic influence. The Georgia State University had the most papers posted. Merlin Didier and Xiao Bo were the scholars who published the most. The research hotspots mainly focus on nanodrug delivery systems, targeted therapy and inflammation regulation, while exosomes, macrophage polarization, and intestinal microbiota regulation are becoming new research frontiers. In the future, intelligent responsive nanomaterials, multifunctional nanoplatforms, and personalized nanotechnology will become important development directions. CONCLUSION: A new avenue for the accurate diagnosis and treatment of IBD has been unlocked by nanotechnology, but its clinical translation needs to break through the bottlenecks of biocompatibility, large-scale preparation and interdisciplinary collaboration. In the future, we should focus on the development of "intelligent responsive nanosystems," deepen the research on the interaction mechanism of "nano-microbe-host," and promote the establishment of a personalized treatment system.

MedicineVol. 105(30)
Southwest Medical University (CN), Affiliated Hospital of Southwest Medical University (CN), First Affiliated Hospital of Sichuan Medical University (CN), Affiliated Hospital of North Sichuan Medical College (CN)
Openalex Percentile: Top 9%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.